J, G., B, Y., J, K., C, Y., & J, R. (2026). Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations. Drugs in R&D, 26(1), 129. https://doi.org/10.1007/s40268-026-00543-y
Chicago Style (17th ed.) CitationJ, Garcia-Olivares, Yegla B, Koch J, Yu C, and Rubin J. "Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations." Drugs in R&D 26, no. 1 (2026): 129. https://doi.org/10.1007/s40268-026-00543-y.
MLA (9th ed.) CitationJ, Garcia-Olivares, et al. "Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations." Drugs in R&D, vol. 26, no. 1, 2026, p. 129, https://doi.org/10.1007/s40268-026-00543-y.